Skip to main content
. 2018 Apr 24;18:300. doi: 10.1186/s12913-018-3095-9

Table 4.

Estimated Diabetes and Insulin-related Healthcare Utilization and Expenditures, by PN Reimbursement Status

Patients with PN Reimbursement
(N = 142)
Patients without PN Reimbursement
(N = 258)
p-value*
Resource Utilization in Prior Six Months
 Number of Diabetes-related Outpatient Visits During Prior Six Monthsa
  Mean (SD) 2.65 (2.8) 2.50 (2.4) 0.2228
  Median (Q1, Q3) 1 (0, 6) 2 (0, 5)
 Any Diabetes-related Hospital Stay During Prior Six Months (% yes)a 13 (9.2) 45 (17.4) 0.0234
 Daily Insulin Dose (in Units)
  Mean (SD) 29.18 (13.7) 34.97 (20.3) 0.0264
  Median (Q1, Q3) 29.5 (18.0, 38.0) 30.0 (20.0, 44.0)
 Daily Insulin Dose per kg of Body Weight
  Mean (SD) 0.45 (0.2) 0.50 (0.3) 0.0414
  Median (Q1, Q3) 0.43 (0.28, 0.58) 0.46 (0.28, 0.65)
Costs in Previous Six Months (reported in 2015 RMB)
 Diabetes-Related Outpatient Costsb
  Mean (SD) 1105 (1160.5) 1040 (1006.9) 0.5576
  Median (Q1, Q3) 416 (0, 2497) 832 (0, 2081)
 Diabetes-Related Hospital Costsb
  Mean (SD) 773 (2717.0) 1589 (4231.8) 0.0388
  Median (Q1, Q3) 0 (0, 0) 0 (0, 0)
 Insulin Costsb
  Mean (SD) 1328 (624.4) 1591 (922.9) 0.0025
  Median (Q1, Q3) 1342 (819, 1729) 1365 (910, 2002)
 Reported OOP Costs
  Mean (SD) 1226 (933.3) 2217 (2079.1) <  0.0001
  Median (Q1, Q3) 995.5 (679, 1580) 1761.9 (891, 2937)
 Total Diabetes-Related Costs
  Mean (SD) 4432 (3376.3) 6433 (5147.2) <  0.0001
  Median (Q1, Q3) 3850 (2135, 5388) 5075 (3441, 7576)

*Differences in continuous variables were tested using Wilcoxon Rank Sum tests and categorical variables (any diabetes-related hospital stay) using χ2 tests; p-values < 0.05 were considered significant

aValues represent outpatient visits and hospital stays during the past 6 months

bUnit costs: 1) insulin costs 0.25 RMB per unit; 2) outpatient/ER visits are 374.1 RMB per visit; 3) and hospital stays are 6581 RMB per stay

BMI Body mass index, DM Diabetes mellitus, kg Kilogram, OOP Out-of-pocket, PN Pen needle, Q1 Lower 25th percentile, Q3 Upper 25th percentile, SD Standard deviation